Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

James Irvin Hudson, M.D.

Co-Author

This page shows the publications co-authored by James Hudson and Harrison Pope.
Connection Strength

15.182
  1. THE CHALLENGES OF METABOLIC SYNDROME IN EATING DISORDERS. Psychiatr Ann. 2020 Aug; 50(8):346-350.
    View in: PubMed
    Score: 0.908
  2. Evolving Perspectives on the Public Health Burden of Eating Disorders. Biol Psychiatry. 2018 09 01; 84(5):318-319.
    View in: PubMed
    Score: 0.798
  3. Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry. 2012 Feb 01; 71(3):254-61.
    View in: PubMed
    Score: 0.489
  4. By how much will the proposed new DSM-5 criteria increase the prevalence of binge eating disorder? Int J Eat Disord. 2012 Jan; 45(1):139-41.
    View in: PubMed
    Score: 0.467
  5. Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder. Am J Clin Nutr. 2010 Jun; 91(6):1568-73.
    View in: PubMed
    Score: 0.447
  6. Ignoring Nina: Avoidance and denial in Pope, Poliakoff, Parker, Boynes, and Hudson. J Trauma Dissociation. 2010; 11(1):19-20; author reply 21.
    View in: PubMed
    Score: 0.437
  7. Genetic epidemiology of eating disorders and co-occurring conditions: the role of endophenotypes. Int J Eat Disord. 2007 Nov; 40 Suppl:S76-8.
    View in: PubMed
    Score: 0.376
  8. Is dissociative amnesia a culture-bound syndrome? Findings from a survey of historical literature. Psychol Med. 2007 Feb; 37(2):225-33.
    View in: PubMed
    Score: 0.354
  9. Binge eating disorder: a stable syndrome. Am J Psychiatry. 2006 Dec; 163(12):2181-3.
    View in: PubMed
    Score: 0.353
  10. Binge-eating disorder as a distinct familial phenotype in obese individuals. Arch Gen Psychiatry. 2006 Mar; 63(3):313-9.
    View in: PubMed
    Score: 0.335
  11. Tracking scientific interest in the dissociative disorders: a study of scientific publication output 1984-2003. Psychother Psychosom. 2006; 75(1):19-24.
    View in: PubMed
    Score: 0.332
  12. Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry. 2004 Dec 01; 56(11):884-91.
    View in: PubMed
    Score: 0.308
  13. Anabolic steroid users' attitudes towards physicians. Addiction. 2004 Sep; 99(9):1189-94.
    View in: PubMed
    Score: 0.302
  14. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry. 2003 Jan; 160(1):105-11.
    View in: PubMed
    Score: 0.269
  15. Review Article: Anabolic-Androgenic Steroids, Violence, and Crime: Two Cases and Literature Review. Am J Addict. 2021 09; 30(5):423-432.
    View in: PubMed
    Score: 0.239
  16. Multivariate logistic regression for familial aggregation of two disorders. II. Analysis of studies of eating and mood disorders. Am J Epidemiol. 2001 Mar 01; 153(5):506-14.
    View in: PubMed
    Score: 0.237
  17. Body image perception among men in three countries. Am J Psychiatry. 2000 Aug; 157(8):1297-301.
    View in: PubMed
    Score: 0.228
  18. Glomerular Filtration Rate and Supraphysiologic-Dose Anabolic-Androgenic Steroid Use: A Cross-sectional Cohort Study. Am J Kidney Dis. 2020 07; 76(1):152-155.
    View in: PubMed
    Score: 0.224
  19. Anabolic-Androgenic Steroid Use and Body Image in Men: A Growing Concern for Clinicians. Psychother Psychosom. 2020; 89(2):65-73.
    View in: PubMed
    Score: 0.221
  20. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry. 2000 Feb; 57(2):133-40; discussion 155-6.
    View in: PubMed
    Score: 0.220
  21. Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? Neurosci Biobehav Rev. 2019 05; 100:180-207.
    View in: PubMed
    Score: 0.206
  22. Eye movement desensitization and reprocessing in eating disorders: caution against premature acceptance. Int J Eat Disord. 1998 Jan; 23(1):1-5.
    View in: PubMed
    Score: 0.190
  23. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017 May 23; 135(21):1991-2002.
    View in: PubMed
    Score: 0.183
  24. The relationship between fibromyalgia and major depressive disorder. Rheum Dis Clin North Am. 1996 May; 22(2):285-303.
    View in: PubMed
    Score: 0.170
  25. "Recovered memory" therapy for eating disorders: implications of the Ramona verdict. Int J Eat Disord. 1996 Mar; 19(2):139-45.
    View in: PubMed
    Score: 0.168
  26. Antidepressant treatment of binge-eating disorder: research findings and clinical guidelines. J Clin Psychiatry. 1996; 57 Suppl 8:73-9.
    View in: PubMed
    Score: 0.166
  27. Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study. Am J Sports Med. 2015 Nov; 43(11):2638-44.
    View in: PubMed
    Score: 0.162
  28. Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2015 Jul 01; 152:47-56.
    View in: PubMed
    Score: 0.158
  29. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction. 2015 May; 110(5):823-31.
    View in: PubMed
    Score: 0.156
  30. Can memories of childhood sexual abuse be repressed? Psychol Med. 1995 Jan; 25(1):121-6.
    View in: PubMed
    Score: 0.155
  31. The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Baillieres Clin Rheumatol. 1994 Nov; 8(4):839-56.
    View in: PubMed
    Score: 0.153
  32. Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response. J Psychiatr Res. 2014 Sep; 56:98-105.
    View in: PubMed
    Score: 0.148
  33. Anorexia nervosa and "reverse anorexia" among 108 male bodybuilders. Compr Psychiatry. 1993 Nov-Dec; 34(6):406-9.
    View in: PubMed
    Score: 0.143
  34. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2014 Jul-Aug; 23(4):371-7.
    View in: PubMed
    Score: 0.142
  35. Polysomnographic characteristics of schizophrenia in comparison with mania and depression. Biol Psychiatry. 1993 Aug 01; 34(3):191-3.
    View in: PubMed
    Score: 0.140
  36. Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2013 Jun 01; 130(1-3):208-14.
    View in: PubMed
    Score: 0.134
  37. Is childhood sexual abuse a risk factor for bulimia nervosa? Am J Psychiatry. 1992 Apr; 149(4):455-63.
    View in: PubMed
    Score: 0.128
  38. Culture, psychosomatics and substance abuse: the example of body image drugs. Psychother Psychosom. 2012; 81(2):73-8.
    View in: PubMed
    Score: 0.126
  39. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction. 2011 Apr; 106(4):777-86.
    View in: PubMed
    Score: 0.118
  40. A supplemental interview for forms of "affective spectrum disorder". Int J Psychiatry Med. 1991; 21(3):205-32.
    View in: PubMed
    Score: 0.117
  41. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry. 1991 Jan; 48(1):62-8.
    View in: PubMed
    Score: 0.117
  42. Human growth hormone abuse in male weightlifters. Am J Addict. 2011 Jan-Feb; 20(1):9-13.
    View in: PubMed
    Score: 0.116
  43. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry. 1990 May; 147(5):552-64.
    View in: PubMed
    Score: 0.112
  44. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail. 2010 Jul; 3(4):472-6.
    View in: PubMed
    Score: 0.112
  45. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol. 2010 Apr; 30(2):126-34.
    View in: PubMed
    Score: 0.111
  46. Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications. Drug Alcohol Depend. 2010 Jun 01; 109(1-3):6-13.
    View in: PubMed
    Score: 0.111
  47. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009 Dec; 104(12):1966-78.
    View in: PubMed
    Score: 0.109
  48. Fibromyalgia and psychopathology: is fibromyalgia a form of "affective spectrum disorder"? J Rheumatol Suppl. 1989 Nov; 19:15-22.
    View in: PubMed
    Score: 0.108
  49. Illicit anabolic-androgenic steroid use. Horm Behav. 2010 Jun; 58(1):111-21.
    View in: PubMed
    Score: 0.107
  50. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol. 1989 Aug; 9(4):254-9.
    View in: PubMed
    Score: 0.106
  51. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study. Hum Psychopharmacol. 2009 Jul; 24(5):423-8.
    View in: PubMed
    Score: 0.106
  52. Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry. 2009 Jun; 166(6):642-5.
    View in: PubMed
    Score: 0.105
  53. Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend. 2009 Jun 01; 102(1-3):130-7.
    View in: PubMed
    Score: 0.104
  54. Role of antiepileptic drugs in the management of eating disorders. CNS Drugs. 2009; 23(2):139-56.
    View in: PubMed
    Score: 0.102
  55. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008 Nov 01; 98(1-2):1-12.
    View in: PubMed
    Score: 0.099
  56. A structural approach to the familial coaggregation of disorders. Epidemiology. 2008 May; 19(3):431-9.
    View in: PubMed
    Score: 0.097
  57. Familiality and heritability of binge eating disorder: results of a case-control family study and a twin study. Int J Eat Disord. 2008 Mar; 41(2):174-9.
    View in: PubMed
    Score: 0.096
  58. Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry. 2008 Feb; 69(2):266-73.
    View in: PubMed
    Score: 0.096
  59. Eating disorder and socioeconomic class. Anorexia nervosa and bulimia in nine communities. J Nerv Ment Dis. 1987 Oct; 175(10):620-3.
    View in: PubMed
    Score: 0.094
  60. Antidepressant medication in the treatment of bulimia nervosa. Psychopathology. 1987; 20 Suppl 1:123-9.
    View in: PubMed
    Score: 0.089
  61. Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend. 2007 May 11; 88(2-3):156-62.
    View in: PubMed
    Score: 0.088
  62. Is PTSD caused by traumatic stress? J Anxiety Disord. 2007; 21(2):176-82.
    View in: PubMed
    Score: 0.088
  63. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Feb 01; 61(3):348-58.
    View in: PubMed
    Score: 0.086
  64. Body image and attitudes toward male roles in anabolic-androgenic steroid users. Am J Psychiatry. 2006 Apr; 163(4):697-703.
    View in: PubMed
    Score: 0.084
  65. Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry. 2005 Oct 15; 58(8):624-31.
    View in: PubMed
    Score: 0.082
  66. The cross-sectional cohort study: an underutilized design. Epidemiology. 2005 May; 16(3):355-9.
    View in: PubMed
    Score: 0.079
  67. Childhood body-focused behaviors and social behaviors as risk factors of eating disorders. Psychother Psychosom. 2005; 74(4):247-53.
    View in: PubMed
    Score: 0.077
  68. Body fat perception in eating-disordered men. Int J Eat Disord. 2004 Jan; 35(1):102-8.
    View in: PubMed
    Score: 0.072
  69. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend. 2003 Jul 20; 71(1):77-86.
    View in: PubMed
    Score: 0.070
  70. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend. 2003 Apr 01; 69(3):303-10.
    View in: PubMed
    Score: 0.068
  71. Family study of affective spectrum disorder. Arch Gen Psychiatry. 2003 Feb; 60(2):170-7.
    View in: PubMed
    Score: 0.068
  72. Pharmacologic treatment of binge eating disorder. Int J Eat Disord. 2003; 34 Suppl:S74-88.
    View in: PubMed
    Score: 0.067
  73. Cognitive measures in long-term cannabis users. J Clin Pharmacol. 2002 11; 42(S1):41S-47S.
    View in: PubMed
    Score: 0.067
  74. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry. 2001 Oct; 58(10):909-15.
    View in: PubMed
    Score: 0.062
  75. Why do young women diet? The roles of body fat, body perception, and body ideal. J Clin Psychiatry. 2001 Aug; 62(8):609-11.
    View in: PubMed
    Score: 0.061
  76. Canadian and American psychiatrists' attitudes toward dissociative disorders diagnoses. Can J Psychiatry. 2001 Jun; 46(5):407-12.
    View in: PubMed
    Score: 0.060
  77. Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom. 2001 May-Jun; 70(3):137-40.
    View in: PubMed
    Score: 0.060
  78. "Body image" drugs: a growing psychosomatic problem. Psychother Psychosom. 2001 Mar-Apr; 70(2):61-5.
    View in: PubMed
    Score: 0.059
  79. Standards for informed consent in recovered memory therapy. J Am Acad Psychiatry Law. 2001; 29(2):138-47.
    View in: PubMed
    Score: 0.059
  80. Muscle dysmorphia in male weightlifters: a case-control study. Am J Psychiatry. 2000 Aug; 157(8):1291-6.
    View in: PubMed
    Score: 0.057
  81. Attitudes toward DSM-IV dissociative disorders diagnoses among board-certified American psychiatrists. Am J Psychiatry. 1999 Feb; 156(2):321-3.
    View in: PubMed
    Score: 0.051
  82. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry. 1998 Dec; 155(12):1756-62.
    View in: PubMed
    Score: 0.051
  83. Questionable validity of 'dissociative amnesia' in trauma victims. Evidence from prospective studies. Br J Psychiatry. 1998 Mar; 172:210-5; discussion 216-7.
    View in: PubMed
    Score: 0.048
  84. Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram. Psychiatry Res Neuroimaging. 2017 Nov 30; 269:9-16.
    View in: PubMed
    Score: 0.047
  85. White matter abnormalities in long-term anabolic-androgenic steroid users: A pilot study. Psychiatry Res Neuroimaging. 2017 Feb 28; 260:1-5.
    View in: PubMed
    Score: 0.044
  86. Fibromyalgia, psychiatric disorders, and assessment of the longterm outcome of eosinophilia-myalgia syndrome. J Rheumatol Suppl. 1996 Oct; 46:37-42; discussion 42-3.
    View in: PubMed
    Score: 0.044
  87. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatr Clin North Am. 1996 Jun; 19(2):351-69.
    View in: PubMed
    Score: 0.043
  88. LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Feb 01; 1(2):116-124.
    View in: PubMed
    Score: 0.042
  89. Anti-Social Behaviors Associated with Anabolic-Androgenic Steroid Use among Male Adolescents. Eur Addict Res. 2015; 21(6):321-6.
    View in: PubMed
    Score: 0.040
  90. REDUCED DISGUST PROPENSITY IS ASSOCIATED WITH IMPROVEMENT IN CONTAMINATION/WASHING SYMPTOMS IN OBSESSIVE-COMPULSIVE DISORDER. J Obsessive Compuls Relat Disord. 2015 Jan 01; 4:20-24.
    View in: PubMed
    Score: 0.039
  91. Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? J Clin Psychiatry. 1995; 56 Suppl 4:41-51; discussion 52.
    View in: PubMed
    Score: 0.039
  92. Childhood sexual abuse and bulimia nervosa: a comparison of American, Austrian, and Brazilian women. Am J Psychiatry. 1994 May; 151(5):732-7.
    View in: PubMed
    Score: 0.037
  93. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull. 1994; 30(2):179-86.
    View in: PubMed
    Score: 0.036
  94. A placebo-controlled trial of acetyl-L-carnitine and a-lipoic acid in the treatment of bipolar depression. J Clin Psychopharmacol. 2013 Oct; 33(5):627-35.
    View in: PubMed
    Score: 0.035
  95. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry. 1993 Feb; 150(2):302-8.
    View in: PubMed
    Score: 0.034
  96. Good sleep, bad sleep: a meta-analysis of polysomnographic measures in insomnia, depression, and narcolepsy. Biol Psychiatry. 1992 Dec 01; 32(11):958-75.
    View in: PubMed
    Score: 0.033
  97. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992 Apr; 92(4):363-7.
    View in: PubMed
    Score: 0.032
  98. Eating disorders in hospitalized substance abusers. Am J Drug Alcohol Abuse. 1992; 18(1):75-85.
    View in: PubMed
    Score: 0.031
  99. Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther. 2011; 37(4):243-54.
    View in: PubMed
    Score: 0.029
  100. Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology. 2010 Feb; 35(3):834-46.
    View in: PubMed
    Score: 0.027
  101. Pharmacological treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol. 1989 Oct; 9(5):358-60.
    View in: PubMed
    Score: 0.027
  102. Valproate in psychiatric disorders: literature review and clinical guidelines. J Clin Psychiatry. 1989 Mar; 50 Suppl:23-9.
    View in: PubMed
    Score: 0.026
  103. Depressive symptoms in bulimic, depressed, and non-psychiatric control subjects. J Affect Disord. 1989 Jan-Feb; 16(1):93-9.
    View in: PubMed
    Score: 0.026
  104. Treatment of bulimia nervosa with trazodone: short-term response and long-term follow-up. Clin Neuropharmacol. 1989; 12 Suppl 1:S38-46; Discussion S47-9.
    View in: PubMed
    Score: 0.026
  105. Valproate in the treatment of rapid-cycling bipolar disorder. J Clin Psychopharmacol. 1988 Aug; 8(4):275-9.
    View in: PubMed
    Score: 0.025
  106. Bulimia in obese individuals. Relationship to normal-weight bulimia. J Nerv Ment Dis. 1988 Mar; 176(3):144-52.
    View in: PubMed
    Score: 0.024
  107. A controlled family history study of bulimia. Psychol Med. 1987 Nov; 17(4):883-90.
    View in: PubMed
    Score: 0.024
  108. A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients. Am J Psychiatry. 1987 Oct; 144(10):1283-7.
    View in: PubMed
    Score: 0.023
  109. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend. 2004 Aug 16; 75(2):135-47.
    View in: PubMed
    Score: 0.019
  110. Attributes of long-term heavy cannabis users: a case-control study. Psychol Med. 2003 Nov; 33(8):1415-22.
    View in: PubMed
    Score: 0.018
  111. Kleptomania: a report of 20 cases. Am J Psychiatry. 1991 May; 148(5):652-7.
    View in: PubMed
    Score: 0.007
  112. Kleptomania: clinical characteristics and associated psychopathology. Psychol Med. 1991 Feb; 21(1):93-108.
    View in: PubMed
    Score: 0.007
  113. Correlates of antimanic response to valproate. Psychopharmacol Bull. 1991; 27(2):127-33.
    View in: PubMed
    Score: 0.007
  114. A controlled study of phenomenology and family history in outpatients with bulimia nervosa. Compr Psychiatry. 1990 Jul-Aug; 31(4):275-83.
    View in: PubMed
    Score: 0.007
  115. Axis II comorbidity of normal-weight bulimia. Compr Psychiatry. 1990 Jan-Feb; 31(1):20-4.
    View in: PubMed
    Score: 0.007
  116. Elevated antidepressant plasma levels after addition of fluoxetine. Am J Psychiatry. 1989 Jul; 146(7):911-3.
    View in: PubMed
    Score: 0.007
  117. Lycanthropy: alive and well in the twentieth century. Psychol Med. 1988 Feb; 18(1):113-20.
    View in: PubMed
    Score: 0.006
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.